Abstract
Our laboratory has developed twelve human breast cancer cell lines from primary and metastatic sites. In this report we demonstrate that eight of eight breast cancer cell lines examined exhibit constitutively tyrosine phosphorylated and enzymatically active endogenous pp125fak when grown in monolayer. The activation status of pp125fak in breast cancer cells in monolayer is significantly elevated over that exhibited by normal mammary epithelial cells cultured under the same conditions. Constitutive activation of pp125fak is the only characteristic so far studied that all of these breast cancer cell lines have in common. In contrast to HBC cells, tyrosine phosphorylation of pp125fak in HME cells was low or absent in monolayer culture but was induced to high levels by culturing the cells in Matrigel. Thus tyrosine phosphorylation and activation of pp125fak is a regulated process in normal mammary epithelial cells, but is constitutive in breast cancer cells. Finally, analysis of the ability of normal human mammary epithelial cells and breast cancer cell lines to grow under anchorage‐independent conditions indicated that normal human mammary epithelial cells rapidly and uniformly lost viability when not substrate‐attached, whereas all of the breast cancer cell lines survived for a 3‐week culture period. Furthermore, a subset of the breast cancer cell lines grew to form large colonies under anchorage‐independent conditions. Interestingly, pp125fak activation decreased dramatically in HBC cells cultured for two weeks in suspension, suggesting that activation of this kinase is not necessary for long‐term growth under anchorage‐independent conditions. These results suggest that constitutive activation of pp125fak results in preferential survival of human breast cancer cells under anchorage‐independent conditions but that activation of pp125fak is not the sole mediator of anchorage‐independent colony formation.
Similar content being viewed by others
References
Ashkenas J, Muschler J, Bissell MJ: The extracellular matrix in epithelial biology: shared molecules and common themes in distant phyla. Development Biology 180: 433–444, 1996
Hynes RO: Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69: 11–25, 1992
Howlett AR, Bailey N, Damsky C, Peterson OW, Bissell MJ: Cellular growth and survival are mediated by beta1 integrins in normal human breast epithelium but not in breast carcinoma. J Cell Sci 108: 1945–1957, 1995
Frisch SM, Francis H: Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124: 619–626, 1994
Meredith JE, Fazeli B, Schwartz MA: The extracellular matrix as a survival factor. Molec Biol Cell 4: 953–961, 1993
Schaller MD, Borgman CA, Cobb BS, Vines RR, Reynolds AB, Parsons JT: pp125FAK, a structurally distinctive protein–tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci USA 89: 5192–5196, 1992
Guan JL, Trevithick JE, Hynes RO: Fibronectin/integrin interaction induces tyrosine phosphorylation of a 120-kDa protein. Cell Regul 2: 951–964, 1991
Guan J-L, Shalloway D: Regulation of focal adhesionassociated protein tyrosine kinase by both cellular adhesion and oncogenic transformation. Nature 358: 690–692, 1992
Hildebrand JD, Schaller MD, Parsons JT: Identification of sequences required for efficient localization of the focal adhesion kinase, pp125fak, to cellular focal adhesions. J Cell Biol 123: 993–1005, 1993
Weiner TM, Liu ET, Craven RJ, Cance WG: Expression of focal adhesion kinase gene in invasive cancer. Lancet 342:1024–1025, 1993
Owens LV, Xu L, Craven RJ, Dent GA, Weiner TM, Kornberg L, Liu ET, Cance WG: Overexpression of focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res 55: 2752–2755, 1995
Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye-binding. Anal Biochem 72: 248–254, 1976
Sambrook J, Frisch EF, Maniatis T: Molecular cloning: a laboratory manual, 2nd edition. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, ME. 1989
Ethier SP, Mahacek ML, Gullick WJ, Frank TJ, Weber BL: Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media. Cancer Res 53: 627–635,1993
Ethier SP, Kokeny KE, Ridings JE, Dilts CA: erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line. Cancer Res 56: 899–907, 1996
Mahacek ML, Beer DG, Frank TS, Ethier SP: Finite proliferative lifespan in vitro of a human breast cancer cell strain isolated from a metastatic lymph node. Breast Cancer Res Treat 28: 267–276, 1993
Sartor CI, Dziubinski ML, Yu C-L, Jove R, Ethier SP: Role of epidermal growth factor receptor and STAT3 activation in autonomous proliferation of SUM-102PT human breast cancer cells. Cancer Res 57: 978–987, 1997
Garcia R, Yu C-L, Hudnall A, Catlett R, Nelson KL, Smithgall T, Fujita DJ, Ethier SP, Jove R: Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Cell Growth Diff 8: 1267–1276, 1997
Freedman VH, Shin S-I: Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium. Cell 3: 355–359, 1974
Frisch SM, Vuori K, Ruoslahti E, Chan-Hui P-Y: Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol 134: 793–799, 1996
Albrechtsen R, Wewer UM, Liotta LA: Basement membranes in human cancer. Pathol Ann 21: 251–276, 1986
Ruoslahti E, Reed JC: Anchorage dependence, integrins, and apoptosis. Cell 77: 477–478–0, 1994
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ignatoski, K.M.W., Ethier, S.P. Constitutive activation of pp125fak in newly isolated human breast cancer cell lines. Breast Cancer Res Treat 54, 173–182 (1999). https://doi.org/10.1023/A:1006135331912
Issue Date:
DOI: https://doi.org/10.1023/A:1006135331912